Exhibit 23.2
Consent of Independent Auditors
We consent to the reference to our firm under the caption "Experts" in
the Registration Statement on Form S-3 and related Prospectus of Shire
Pharmaceuticals Group plc for the registration of 21,214,628 of its ordinary
shares and to the incorporation by reference therein of our report dated
February 16, 1999, with respect to the consolidated financial statements of
Roberts Pharmaceutical Corporation for the year ended December 31, 1998,
included in the Shire Pharmaceuticals Group plc Annual Report on Form 10-K for
the year ended December 31, 1999, filed with the Securities and Exchange
Commission.
/s/ Ernst & Young LLP
MetroPark, New Jersey
June 16, 2000